₹33.5
▲ +0.12 +0.36%
As of 28 Oct 2026 · delayed
BSE Listed
ANG Lifesciences India Limited (540694)
Volume: 2,192Avg Vol 1W: 2,503Avg Vol 1M: 2,66952W Range:₹17.63₹49.69
Key Ratios
Checked 7h agoMarket Cap₹44 Cr
Current Price₹33.5
Previous Close₹33.38
High / Low (52w)₹49.69 / ₹17.63
Volume2,192
Avg Vol (1W)2,503
Avg Vol (1M)2,669
Stock P/E—
Book Value₹36.91
Dividend Yield0%
ROE-20.96%
ROA-6.37%
Revenue (TTM)—
Revenue Growth—
Profit Margin-15.94%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0.91
Debt / Equity1.39
50 DMA₹34.57
200 DMA₹29.72
Day change+0.36%
Price Chart
₹33.5▲ 2.48% · 1Y
2025-10-282026-10-28
20-day avg volume: 3K shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 85% YoY.
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹33 Cr | ₹25 Cr | ₹17 Cr | ₹25 Cr | ₹26 Cr | ₹19 Cr | ₹24 Cr | ₹15 Cr |
| EBITDA | ₹1 Cr | ₹-4 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹-4 Cr | ₹1 Cr | ₹-3 Cr |
| Net Profit | ₹-2 Cr | ₹-5 Cr | ₹-2 Cr | ₹-2 Cr | ₹-3 Cr | ₹-5 Cr | ₹-1 Cr | ₹-4 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹18 Cr | ₹95 Cr | ₹25 Cr | ₹26 Cr | ₹18 Cr | ₹93 Cr | ₹23 Cr | ₹14 Cr |
| EBITDA | ₹-1 Cr | ₹-7 Cr | ₹1 Cr | ₹1 Cr | ₹-3 Cr | ₹-5 Cr | ₹3 Cr | ₹-3 Cr |
| Net Profit | ₹-2 Cr | ₹-12 Cr | ₹-1 Cr | ₹-1 Cr | ₹-4 Cr | ₹-11 Cr | ₹1 Cr | ₹-3 Cr |
| EPS | — | -9.42 | — | — | — | -8.43 | — | — |
Balance Sheet
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | ₹291 Cr | ₹278 Cr | ₹242 Cr | ₹230 Cr | ₹209 Cr |
| Total Liabilities | ₹207 Cr | ₹191 Cr | ₹166 Cr | ₹166 Cr | ₹156 Cr |
| Equity | ₹84 Cr | ₹86 Cr | ₹76 Cr | ₹64 Cr | ₹53 Cr |
| Total Debt | — | — | — | — | — |
Cash Flow
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | ₹25 Cr | ₹30 Cr | ₹4 Cr | ₹4 Cr | ₹11 Cr |
| Investing | ₹-44 Cr | ₹-9 Cr | ₹20 Cr | ₹-2 Cr | ₹1 Cr |
| Financing | ₹20 Cr | ₹-17 Cr | ₹-10 Cr | ₹2 Cr | ₹-12 Cr |
| Free Cash Flow | ₹25 Cr | ₹30 Cr | ₹4 Cr | ₹4 Cr | ₹11 Cr |
Shareholding
Promoter 70.6% Institutions 0% Public 29.4%
Efficiency & Working Capital
ROCE-3.8%
Interest Coverage-0.4
Dividend Payout—
Debtor Days267 d
Inventory Days182 d
Payable Days206 d
Cash Conversion Cycle242 d
Working Capital Days449 d
Shareholding Details
As of 2026-09-30
Promoter70.6%
FII0%
DII0%
Institutions0%
Public29.4%
Promoter Pledge44.9%
No. of Shareholders5,666
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% |
| Promoter Pledge | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% |
| No. of Shareholders | 6,918 | 6,868 | 6,631 | 6,468 | 6,517 | 6,508 | 6,400 | 6,273 | 6,084 | 5,952 | 5,946 | 5,666 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Rajesh Gupta | Shareholding of Promoter and Promoter Group | 70.4% | 91,94,537 |
| Saruchi Gupta | Shareholding of Promoter and Promoter Group | 0.2% | 25,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Rajesh Gupta | 41,37,500 | 45% | 2026-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Rajesh Gupta | Executive Director & MD | 2025 |
| Saruchi Gupta | Executive Director / Whole Time Director / CFO | 2025 |
| Rohit Mittal | Non Executive Director | 2025 |
| Harvinder Singh Dhami | Independent Non Exe. Director | 2025 |
| Sukhpal Singh | Independent Non Exe. Director | 2025 |
| Chetna | Independent Non Exe. Director | 2025 |
| Harshita Aggarwal | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Outside India | ₹5 Cr | 5.6% |
| Within India | ₹85 Cr | 94.4% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 14 | 13 | 13 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-14 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 9 | 0 | 0 | 19 | 10 | 37 |
| 2025 | 4 | 0 | 0 | 17 | 0 | 21 |
| 2025 | 2 | 0 | 0 | 1 | 0 | 4 |
Company Information
🌐 www.anglifesciences.com ↗
📍 Darbara Complex SCO 113 I Flr, Dist. Shopping Centre B Block, Amritsar, Punjab, 143001
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search
